{"id":"https://openalex.org/W4240617032","doi":"https://doi.org/10.1158/1538-7445.am2017-5162","title":"Abstract 5162: Development of a dual inhibitor of pan-RAF and angiogenesis for the treatment of metastatic colorectal cancer with mutant K-RAS","display_name":"Abstract 5162: Development of a dual inhibitor of pan-RAF and angiogenesis for the treatment of metastatic colorectal cancer with mutant K-RAS","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W4240617032","doi":"https://doi.org/10.1158/1538-7445.am2017-5162"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2017-5162","doi":"https://doi.org/10.1158/1538-7445.am2017-5162","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-5162","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Sungpyo Hong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146429904","display_name":"Incheon National University","ror":"https://ror.org/02xf7p935","country_code":"KR","type":"education","lineage":["https://openalex.org/I146429904"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sungpyo Hong","raw_affiliation_strings":["1Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon, Republic of Korea;","institution_ids":["https://openalex.org/I146429904"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102008780","display_name":"Young-Hoon Choi","orcid":"https://orcid.org/0009-0009-4204-8815","observed_orcids":["https://orcid.org/0009-0009-4204-8815"]},"institutions":[{"id":"https://openalex.org/I146429904","display_name":"Incheon National University","ror":"https://ror.org/02xf7p935","country_code":"KR","type":"education","lineage":["https://openalex.org/I146429904"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Younghoon Choi","raw_affiliation_strings":["1Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon, Republic of Korea;","institution_ids":["https://openalex.org/I146429904"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082457581","display_name":"Ho\u2010Seok Kwon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096655","display_name":"Samjin Pharm (South Korea)","ror":"https://ror.org/00t3nxd66","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210096655"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Ho-Seok Kwon","raw_affiliation_strings":["2Samjin Pharm. Co. Ltd, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Samjin Pharm. Co. Ltd, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I4210096655"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113580506","display_name":"Yong Bin Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096655","display_name":"Samjin Pharm (South Korea)","ror":"https://ror.org/00t3nxd66","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210096655"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Yong Bin Park","raw_affiliation_strings":["2Samjin Pharm. Co. Ltd, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Samjin Pharm. Co. Ltd, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I4210096655"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103985052","display_name":"Min-Hyo Ki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096655","display_name":"Samjin Pharm (South Korea)","ror":"https://ror.org/00t3nxd66","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210096655"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Min-Hyo Ki","raw_affiliation_strings":["2Samjin Pharm. Co. Ltd, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Samjin Pharm. Co. Ltd, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I4210096655"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081110535","display_name":"Hee Jong Shin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096655","display_name":"Samjin Pharm (South Korea)","ror":"https://ror.org/00t3nxd66","country_code":"KR","type":"company","lineage":["https://openalex.org/I4210096655"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hee Jong Shin","raw_affiliation_strings":["2Samjin Pharm. Co. Ltd, Seoul, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Samjin Pharm. Co. Ltd, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I4210096655"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103569319","display_name":"Michael Lee","orcid":"https://orcid.org/0009-0006-7046-6457","observed_orcids":["https://orcid.org/0009-0006-7046-6457"]},"institutions":[{"id":"https://openalex.org/I146429904","display_name":"Incheon National University","ror":"https://ror.org/02xf7p935","country_code":"KR","type":"education","lineage":["https://openalex.org/I146429904"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Michael Lee","raw_affiliation_strings":["1Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon, Republic of Korea;","institution_ids":["https://openalex.org/I146429904"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102736354","display_name":"Soon Kil Ahn","orcid":"https://orcid.org/0000-0002-9173-5963","observed_orcids":["https://orcid.org/0000-0002-9173-5963","https://orcid.org/0000-0002-6696-8116"]},"institutions":[{"id":"https://openalex.org/I146429904","display_name":"Incheon National University","ror":"https://ror.org/02xf7p935","country_code":"KR","type":"education","lineage":["https://openalex.org/I146429904"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Soon Kil Ahn","raw_affiliation_strings":["1Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon, Republic of Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Institute for New Drug Development, Division of Life Sciences, Incheon National University, Incheon, Republic of Korea;","institution_ids":["https://openalex.org/I146429904"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"77","issue":"13_Supplement","first_page":"5162","last_page":"5162"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.7275000214576721,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.7275000214576721,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.13179999589920044,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.05130000039935112,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.5860000252723694},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.9259999990463257},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.8029999732971191},{"id":"https://openalex.org/keywords/mapk-erk-pathway","display_name":"MAPK/ERK pathway","score":0.9039999842643738},{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.7400000095367432},{"id":"https://openalex.org/keywords/tie2","display_name":"Tie2","score":0.8640000224113464},{"id":"https://openalex.org/keywords/anti-vegf-therapy-resistance","display_name":"anti-VEGF therapy resistance","score":0.7730000019073486},{"id":"https://openalex.org/keywords/mek-erk-phosphorylation","display_name":"MEK/ERK phosphorylation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8695688247680664},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.7845114469528198},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7359862923622131},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6840596199035645},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.674609899520874},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5259318947792053},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5092939138412476},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.4943568706512451},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.48254698514938354},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4661387801170349},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3378445506095886},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3231821060180664},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2646633982658386},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1901721954345703},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10569092631340027},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06932693719863892}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2017-5162","doi":"https://doi.org/10.1158/1538-7445.am2017-5162","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2017-5162","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2499892494","https://openalex.org/W2113959336","https://openalex.org/W4380611121","https://openalex.org/W4384300516","https://openalex.org/W2567259523","https://openalex.org/W2064474801","https://openalex.org/W317545","https://openalex.org/W1576318301","https://openalex.org/W2072429445","https://openalex.org/W178049979"],"abstract_inverted_index":{"Abstract":[0],"Colorectal":[1],"cancer(CRC)":[2],"is":[3,97,124,188],"one":[4],"of":[5,14,28,40,61,76,103,110,119,156,163,202,224,241,254,259,303,316,350,378,382,389,399],"the":[6,18,45,54,58,74,79,101,108,120,131,161,186,220,239,252,333,348,387,400],"most":[7],"common":[8],"cancers":[9,112],"and":[10,89,153,204,211,234,299,318,384],"a":[11,98,213,379],"leading":[12],"cause":[13],"cancer-related":[15],"death":[16],"in":[17,26,63,127,144,246,275,283,292],"western":[19],"world.":[20],"K-RAS":[21,67,114,128,247,264,276,298,327,395],"mutation":[22],"has":[23,321],"been":[24,35,136,322],"reported":[25],"40%":[27],"colorectal":[29,111,260,278,286,293,328,351,391],"cancer":[30,261,279,287,294,329,352,392],"patients.":[31],"KRAS":[32],"mutations":[33],"have":[34,135],"significantly":[36],"associated":[37],"with":[38,44,113,263,296,353,393],"lack":[39],"response":[41],"to":[42,78,174,192,198,219,324],"treatment":[43,59,109,349,388],"anti-EGFR":[46],"or":[47,86,265],"anti-BRAF.":[48],"The":[49],"FDA":[50],"approved":[51],"Bevacizumab":[52,83],"as":[53,182],"anti-angiogenic":[55],"agent":[56],"for":[57,100,107,347,386,403],"standard":[60],"care":[62],"metastatic":[64,390],"CRC.":[65],"However,":[66,138],"status":[68],"does":[69],"not":[70,273],"show":[71],"benefit":[72,88],"from":[73],"incorporation":[75],"bevacizumab":[77],"first-line":[80],"IFL":[81],"chemotherapy.":[82],"provides":[84],"modest":[85],"no":[87],"almost":[90],"inevitably":[91],"causes":[92],"therapeutic":[93,105,179],"resistance.":[94],"Therefore,":[95,195],"there":[96],"need":[99],"development":[102,162],"new":[104],"approaches":[106],"mutation.":[115,267],"Because":[116,185],"aberrant":[117],"activation":[118,155,245],"RAF-":[121],"MAPK":[122,334],"pathway":[123,187],"frequently":[125],"found":[126],"mutant":[129,146,248,277,285,297,326,354,394],"cancer,":[130],"B-RAF":[132,139,231,266,284],"specific":[133,140],"inhibitors":[134,165,201],"tested.":[137],"inhibitor":[141,315,381],"activates":[142],"C-RAF":[143],"RAS":[145],"cells":[147,262,280,330],"by":[148],"inducing":[149,167],"RAF":[150],"dimer":[151],"formation":[152],"paradoxical":[154,168,244],"C-RAF.":[157],"These":[158],"observations":[159],"require":[160],"pan-RAF":[164,203,317,383],"without":[166,243,331],"activation.":[169],"In":[170,306],"addition,":[171],"acquired":[172],"resistance":[173],"anti-VEGF":[175],"therapy":[176],"needs":[177],"another":[178],"target,":[180],"such":[181],"angiopoietin-TIE2":[183],"system.":[184],"induced":[189],"after":[190],"exposure":[191],"anti-VEGF/VEGFR":[193],"drugs.":[194],"we":[196,309],"tried":[197],"find":[199],"dual":[200,314,380],"angiogenesis":[205,385],"using":[206],"structure":[207],"based":[208],"molecular":[209],"modeling":[210],"identified":[212],"selective":[214],"inhibitor,":[215],"SJ-C1044,":[216],"which":[217],"binds":[218],"DFG-out":[221],"inactive":[222],"conformation":[223],"B-RAF.":[225],"SJ-C1044":[226,236,255,268,291,320,340],"potentially":[227],"inhibited":[228,238],"B-RAF,":[229],"C-RAF,":[230],"V600E,":[232],"VEGFR2":[233],"Tie2.":[235],"completely":[237],"phosphorylation":[240],"MEK-ERK":[242],"cells.":[249,288],"We":[250,289],"examined":[251],"effects":[253],"on":[256],"cell":[257],"proliferation":[258],"displayed":[269],"potent":[270],"anti-proliferative":[271],"activities":[272],"only":[274],"but":[281],"also":[282],"tested":[290],"xenografts":[295],"observed":[300],"97%":[301],"reduction":[302],"tumor":[304],"volume.":[305],"this":[307],"study,":[308],"discovered":[310],"an":[311,343],"orally":[312],"active":[313],"angiogenesis.":[319],"shown":[323],"suppress":[325],"activating":[332],"pathway.":[335],"Our":[336],"findings":[337],"suggest":[338],"that":[339],"could":[341],"be":[342],"excellent":[344],"preclinical":[345],"candidate":[346],"K-RAS.":[355],"Citation":[356],"Format:":[357],"Sungpyo":[358],"Hong,":[359],"Younghoon":[360],"Choi,":[361],"Ho-Seok":[362],"Kwon,":[363],"Yong":[364],"Bin":[365],"Park,":[366],"Min-Hyo":[367],"Ki,":[368],"Hee":[369],"Jong":[370],"Shin,":[371],"Michael":[372],"Lee,":[373],"Soon":[374],"Kil":[375],"Ahn.":[376],"Development":[377],"[abstract].":[396],"In:":[397],"Proceedings":[398],"American":[401],"Association":[402],"Cancer":[404,417],"Research":[405],"Annual":[406],"Meeting":[407],"2017;":[408],"2017":[409],"Apr":[410],"1-5;":[411],"Washington,":[412],"DC.":[413],"Philadelphia":[414],"(PA):":[415],"AACR;":[416],"Res":[418],"2017;77(13":[419],"Suppl):Abstract":[420],"nr":[421],"5162.":[422],"doi:10.1158/1538-7445.AM2017-5162":[423]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2022-05-12T00:00:00"}